The gift marks the largest contribution to the LMU Catholic High School Promise Program and represents a transformative investment in creating accessible pathways to higher education for local students, rooted in opportunity, formation, and service.

LOS ANGELES, Oct. 2, 2026 /PRNewswire/ -- Loyola Marymount University on Thursday announced a transformative $5.57 million gift from the Marymount Education Foundation (MEF) that provides a seamless pathway and comprehensive financial support for local Catholic high school students to attend LMU.

The gift establishes the Marymount Scholars Program, a mission-aligned partnership between LMU, MEF and the Archdiocese of Los Angeles to expand access to higher education for students facing socio-economic and other barriers to attend a four-year college. Rooted in a shared commitment to Catholic education and the formation of students as whole persons from grade school through college, the program represents a meaningful investment in the promise and potential of Los Angeles and LMU students.

See the press kit with b-roll and images.

"The Marymount Education Foundation's generous commitment to LMU underscores how partners with shared values and a bold vision can create pathways to expand access to higher education," said LMU President Thomas Poon. "This program will transform the lives of more than 70 ambitious and talented Catholic high school students considering LMU as their college home."

"I am delighted by this new partnership, which will make Catholic education more affordable and more available to young people in our archdiocese," said Archbishop José H. Gomez. "It is a great example of what we can do when we work together, and I look forward to a long relationship between our Catholic schools and Loyola Marymount University."

The gift will support up to 18 new students annually who are part of the LMU Catholic High School Promise Program, a pioneering academic partnership established in 2025 between LMU and the archdiocese's Department of Catholic Schools. The Marymount Education Foundation's commitment marks the program's largest gift to date.

The Marymount Scholars Program guarantees admission and provides comprehensive financial support and resources for qualified high school senior students annually from LMU Catholic High School Promise Program's six participating high schools: Bishop Conaty–Our Lady of Loretto High School, Bishop Mora Salesian, Cantwell–Sacred Heart of Mary College Prep, Junípero Serra High School, St. Bernard College Prep, and St. Pius X–St. Matthias Academy. The Promise Program's first cohort – members of the LMU Class of 2030 – joined the university at the start of the 2026-27 academic year.

"MEF is gratified that its support will remove barriers for dozens of local high school students who select LMU as their college of choice," said MEF Founding Executive Director Robyn Jones. "Expanding access to higher education and creating pathways to help students achieve lifelong success are key elements of the foundation's mission."

More than simply financial support, the Marymount Scholars Program enables students to participate fully in the LMU experience and thrive through graduation – with access to faculty mentorship, career and professional development resources, stipends towards study abroad opportunities, funding for technology, laptops, and books, and ongoing support and progress monitoring. Marymount Scholars are offered one-on-one support with foundation mentors throughout their four years in the program – from campus visits to career coaching sessions – setting them up for success during their academic careers and after graduation.

"As a graduate of St. Bernard College Prep and growing up in the Los Angeles area, I was drawn to LMU after taking a tour in middle school and because of LMU's Catholic values," said Chibby Obi, LMU first-year student and LMU Catholic High School Promise Program Scholar. "The LMU Catholic High School Promise Program helped make the dream of college a reality for me. Having the ongoing support of the program and getting to know my cohort peers has made me excited for the four years ahead."

For LMU, the new Marymount Scholars Program advances the university's mission to educate the whole person in the service of faith and the promotion of justice. By investing in students whose experiences and perspectives enrich the campus community, and providing sustained mentorship opportunities and academic support, the program strengthens LMU's commitment to fostering educational access and empowering future leaders to create positive change in their communities.

SOURCE Loyola Marymount University

Share this article

Employee Stock Ownership Plan marks a new chapter for the company after nearly 24 years of Huizenga Group ownership

GRAND RAPIDS, Mich., Oct. 2, 2026 /PRNewswire/ -- Employees of Parkway Electric & Communications gathered on September 15 at the Pinnacle Center for the company's annual meeting. This year's announcements included a blockbuster surprise: there were new owners of the company and they (the employees) were the proud new owners.

Parkway announced that it has transitioned to 100% employee ownership through an Employee Stock Ownership Plan (ESOP), giving eligible employees the opportunity to build an ownership interest in the company and benefit financially from its future success.

Ryan Pate, an Electrical Site Superintendent, who has been with Parkway for 28 years, described what the announcement meant personally: "I've spent 28 years helping build Parkway, and I've always been proud to work here. Hearing that we are becoming owners was something special. It recognizes what our people have contributed to this company and gives all of us an even greater stake in what we build together going forward."

Huizenga Group acquired Parkway in December 2002 and has owned and stewarded the company for nearly 24 years. During that time, Parkway has continued to grow its capabilities and reputation as a provider of comprehensive electrical, communications, controls and audio visual services.

As Huizenga Group considered the company's long-term future, it evaluated a number of alternatives, including a potential sale to an outside buyer. Ultimately, it concluded that transitioning ownership to Parkway's employees offered the best opportunity to recognize the people who created the company's value while preserving Parkway's independence, culture and long-standing customer relationships.

"We've been grateful for the success we have achieved at Parkway for nearly 24 years," said J.C. Huizenga, Chairman of Huizenga Group. "As we thought about the future, we had a number of options, including selling the company to an outside buyer. But Parkway has always been about its people. They are the ones who built the company, serve our customers and created the value that exists today. We concluded that the best way to honor that legacy was to transition ownership to the employees themselves. It allows Parkway to remain independent, protects the culture that has made it successful and gives employees the opportunity to share in the value they help create. We think that's good for the employees, good for our customers and good for Parkway's long-term future."

For Doug Mitchell, President of Parkway Electric & Communications, the transition creates an opportunity to build on Parkway's history while strengthening the connection between its employees, customers and future success.

"Our customers have trusted Parkway because of the quality of our work and the people who stand behind it," Mitchell said. "That doesn't change. They will continue to work with the same team and receive the same commitment to quality, service and problem-solving they expect from Parkway. What employee ownership does is give our people an even greater stake in delivering on those commitments and in building Parkway for the long term. I'm excited about what that can mean for our employees, our customers and the future of the company."

The ESOP provides eligible employees with a financial interest in Parkway's future while allowing the company to remain independent. The transition does not change Parkway's day-to-day operations, leadership or commitment to its customers.

The move to employee ownership represents both the culmination of nearly 24 years of Huizenga Group stewardship and the beginning of a new chapter for Parkway — one in which the people responsible for the company's continued success will also have the opportunity to share in the value they create.

About Parkway Electric & Communications

Parkway Electric & Communications provides comprehensive electrical, communications, controls and audio visual services, from design and build through repair and maintenance. The company serves customers with a broad range of capabilities and a commitment to quality, service and long-term relationships.

About Huizenga Group

Huizenga Group is a privately held West Michigan investment firm with roots dating to 1985. The firm invests in and provides management services to a diverse group of businesses spanning automation, tool and die, electrical contracting, machined components and other industrial sectors. Huizenga Group focuses on middle-market commercial and industrial businesses and has a long-standing commitment to building enduring economic growth and creating value for its companies, employees, shareholders and the West Michigan region.

SOURCE Huizenga Group

Share this article

New national survey of 5,000 Americans finds the obstacle isn't death, it's timing: Christmas is the occasion families avoid most, while a birthday party rates harder than a funeral.

SAN DIEGO, Oct. 2, 2026 /PRNewswire/ -- Trust & Will, the leading digital estate planning platform, today released its 2026 Death & Inheritance Report, a national survey of 5,000 U.S. adults examining when, where, and why American families talk about death, inheritance, and estate planning. The findings overturn some of the most common assumptions about timing. Americans find it easier to discuss death at a funeral than at a birthday party. Christmas, not a somber occasion, is the single moment families avoid the topic most. And the families who do talk about it mostly do so on an ordinary day, with no occasion attached at all.

This is the first year Trust & Will has fielded a study devoted entirely to the conversation that precedes the paperwork. It follows the company's 2026 Estate Planning Report, which found that 56% of U.S. adults have no estate planning documents in place, and extends that research to ask a more fundamental question: why do so many families never even talk about it?

The Inheritance Conversation Doesn't Happen Where You'd Expect

The cultural script says families talk about inheritance over Thanksgiving dinner. The data says otherwise. Thanksgiving is the eighth most common occasion prompting these conversations, named by just 6% of Americans, and only 5% say their most recent conversation actually happened there. The single most common answer is that no occasion prompts it at all: 22% of Americans say the subject simply comes up, with no event attached, and 38% of the most recent conversations took place during an ordinary visit or phone call.

Christmas Is the Occasion Americans Protect, Not the One They Use

Christmas holds a contradictory position in the data. It is the most common holiday trigger for these conversations, named by 16% of Americans. It is also the occasion Americans would most actively avoid for the same conversation, named by 37%, more than double any other occasion, and it ranks first for avoidance in all 50 states.

Why a Birthday Is Harder to Talk About Inheritance Than a Funeral

Trust & Will asked respondents to rate how awkward it would feel to raise estate planning at five specific occasions. A family member's birthday is the most awkward occasion in the country for this conversation, rated awkward by 63% of Americans, higher than Thanksgiving dinner (62%) or a major sporting event (59%). A funeral or wake, by contrast, is rated awkward by just 41%, and an ordinary phone call is the easiest setting of all, at 32%. The gap between the hardest celebration and the easiest non-celebration is 18 points.

"We expected families to put this off because it's about death. What the data actually shows is that they put it off because it's about joy, and nobody wants to be the one who brings estate planning to a birthday party," said Cody Barbo, Co-Founder and CEO, Trust & Will. "Once you see it that way, the fix is obvious. You don't need a special occasion. You need an ordinary Tuesday."

Nearly Half of Americans Expect an Inheritance They Have Never Discussed

46% of Americans expect to receive an inheritance, and half of that group has never had it formally confirmed with the person leaving it. 12% of Americans expecting an inheritance expect to inherit debts or liabilities. Among the 4,304 respondents who lost a close family member in the past five years, 40% say that person died without a complete estate plan in place: 28% with no plan at all, 12% with one that was incomplete or out of date.

The Information Gap Between Who Starts the Conversation and Who Knows the Answer

Women are more likely than men to start these conversations in their own families, 42% to 38%, and their conversations cover more topics. But 56% of men know where their family's estate documents are kept, compared with 44% of women, and men are more likely to expect an inheritance (55% vs. 40%). The pattern holds even after accounting for age. The person doing the work of starting the conversation is not reliably the person who ends up holding the information.

What Actually Gets Families Talking

Two things move a family from silence to conversation, and neither is a holiday. Americans who lost a close family member in the past year are more than twice as likely to have discussed inheritance recently (65% vs. 31% for those without a recent loss). And having a plan of one's own appears to be contagious across generations: Americans with a completed will or trust are more than three times as likely to say the relative they lost also had one (63% vs. 18%).

Where You Live Changes the Occasion, Not the Outcome

Regional differences are real but modest, with one exception. The Southeast is most likely to use Christmas as a trigger for the conversation and least likely to avoid it; the West shows the exact reverse. State-level findings ranked across all five occasions show New York is the hardest state in the country for raising the topic on an ordinary phone call (50% rate it awkward, vs. 32% nationally), while North Dakota is the easiest state in the country on three of the five occasions measured. Kentucky has the highest share of residents who have never had this conversation at all, at 36%.

To view the full report, including downloadable charts and graphics, visit: trustandwill.com/learn/death-and-inheritance-report

About Trust & Will

Founded in 2017, Trust & Will is the leading digital estate planning platform in the U.S., trusted by over one million families. Our simple, secure, and attorney-approved online solutions empower Americans to create wills, trusts, healthcare directives, and other essential estate planning documents tailored to state-specific laws. As a certified B Corporation and Public Benefit Corporation, our mission to help every family leave a meaningful legacy is embedded into our business model, ensuring estate planning is accessible, affordable, and inclusive for all.

Trust & Will is advancing modern legacy planning with AI-driven innovation, helping families and professionals simplify complex decisions and accelerate collaborative workflows.

Our platform supports 26,000+ financial advisors and 145+ enterprise partners, including banks, financial institutions, attorneys, nonprofits, real estate agents, and technology platforms. Notable partners include AARP, Fifth Third Bank, UBS, USAA, LPL Financial, and Northwestern Mutual. With more than one million users and over $300 billion in self-reported estate assets, Trust & Will is redefining estate planning as a strategic pillar of modern financial wellness.

Trust & Will has been consistently recognized for innovation and leadership in 2026, earning a spot on the Inc. 5000 for a fourth consecutive year, Fast Company's World's Most Innovative Companies, the Financial Times' Americas' Fastest-Growing Companies, the Inc. Regionals: Fastest-Growing Private Companies, and Forbes' America's Best Startup Employers. The company also won Best Fintech Partnership at the 2026 Finovate Awards and Thought Leadership, Estate Planning at the 2026 Wealth Management ("Wealthies") Industry Awards, was a finalist across five categories at the 2026 ThinkAdvisor Luminaries Awards, and was named "best for families" in CNBC Select's ranking of the best online will-makers of 2026.

Learn more at trustandwill.com.

SOURCE Trust & Will

Share this article

PALMA DE MALLORCA, Spain, Oct. 2, 2026 /PRNewswire/ -- Smartee Denti-Technology concluded the Smartee European Summit 2026 in Palma de Mallorca, Spain, on September 19, marking the company's first large-scale academic summit held outside China.

The two-day event brought together nearly 300 orthodontic experts and clinicians from 27 countries. Discussions covered GS Mandibular Repositioning Technology, the management of complex malocclusions, early orthodontic treatment, dental sleep medicine and airway-related care, alongside the international launch of two new products - Smartee SA/SA Plus and Smartee AG KIDS.

Opening the Summit, Junfeng Yao, Founder and CEO of Smartee, shared how the company is incorporating artificial intelligence into its products and systems, as well as into internal workflows designed to improve the efficiency of clinical support for doctors.

Across the two-day program, speakers from Europe and Asia shared clinical cases, research developments and treatment perspectives across several areas of orthodontic practice.

Exploring GS Technology and Complex Malocclusion Management

The first day focused on GS Mandibular Repositioning Technology and its clinical application in the management of malocclusions involving mandibular positional discrepancies.

Prof. Gang Shen of Taikang ByBo Dental, Chief Scientist for Smartee's GS R&D, opened the scientific program with a presentation on the development and clinical philosophy of the GS system. Together with Dr. Xingxing Wang, Clinical Medical Director at Smartee, he introduced the clinical rationale and application of mandibular repositioning from a three-dimensional perspective.

The program also featured Prof. Thomas Felkai of Semmelweis University in Hungary, Dr. Katarzyna Łoza-Sołtyk, President of the European Society of Lingual Orthodontics and Founder and Clinical Director of Soldent Clinic in Warsaw, Dr. Pratik Sharma, Chairman of the Orthodontic Specialist Advisory Board at the Royal College of Surgeons of Edinburgh, and Mr. Matthias Peper, Founder and CEO of TP SOLUTION; as well as experienced orthodontists Dr. Carmen Pérez and Dr. María del Pilar Pérez.

Through clinical cases, speakers discussed diagnosis, treatment objectives, mandibular position assessment and treatment pathway selection for different types of malocclusion involving mandibular positional factors, including mandibular retrognathia, asymmetric Class II malocclusion and adult Class II treatment.

Speaking after the Summit, Prof. Shen emphasized that appropriate patient selection is an important prerequisite for mandibular repositioning.

"Mandibular position needs to be evaluated in the sagittal, vertical and transverse dimensions," he said. "The first step is to determine whether an abnormal mandibular position is present and then assess the direction of the discrepancy from a three-dimensional perspective."

He added that mandibular repositioning may offer an additional clinical approach for selected adults with Class II malocclusion, while further international clinical research and practice will be important as the field continues to develop.

Extending the Discussion to Early Orthodontics and Dental Sleep Medicine

The second day expanded the scientific program into two areas: early orthodontic treatment and clinical management for growing patients, and obstructive sleep apnea treatment and airway management.

The early orthodontics sessions examined treatment timing, interceptive treatment, craniofacial growth, airway-related assessment and orofacial myofunction therapy — spanning biological principles, clinical decision-making, and treatment approaches.

Speakers included Prof. Shen; Dr. Vicente Torres, Collaborating Professor of Orthodontics at the University of Valencia; Prof. Jane Shi, an expert in orofacial myofunctional therapy and an Examiner of the International Association of Orofacial Myology (IAOM); and Dr. Steffen Decker, the clinical lead of The Orthodontic Specialist and founder of GrowIQ Dental Academy; and experienced orthodontist Dr. Isabel Vélez Lagune.

The discussions reflected a broader approach to the assessment of growing patients, incorporating growth stage, craniofacial development, respiratory patterns and orofacial function alongside dental and occlusal considerations.

In a post-Summit interview, Prof. Jane Shi highlighted the importance of evaluating airway, breathing patterns and orofacial myofunction when developing early orthodontic treatment plans.

She noted that signs such as mouth breathing, abnormal tongue posture and narrow dental arches may indicate the need for further functional or multidisciplinary assessment, depending on the individual patient.

The afternoon sessions turned to dental sleep medicine and airway management.

Speakers included Prof. Antonio Gracco, Director of the Postgraduate School of Orthodontics at the University of Padua and former President of the Italian Academy of Dental Sleep Medicine; Dr. Francesca Milano, Adjunct Professor at the University of Padua and former President of the European Academy of Dental Sleep Medicine; and Dr. Yue Weng Cheu, Clinical Director at DP Dental in Singapore and Advisory Panel Member, Diploma in Oral Health Therapy at Nanyang Polytechnic.

Their presentations addressed scientific evidence in dental sleep medicine, the application of clear aligner technology in sleep-related care, and the relationship between pediatric airway considerations and craniofacial development.

Dr. Yue, the principal clinical collaborator of Smartee's newly launched product - AG KIDS, emphasized that orthodontists may identify potential risk indicators during routine clinical assessment, while the diagnosis of sleep-related breathing disorders should remain within the appropriate medical specialties.

For children presenting with higher-risk signs, he noted that further evaluation and management should involve appropriate multidisciplinary referral.

Prof. Gracco also shared clinical perspectives on snoring, obstructive sleep apnea and mandibular advancement appliances. He noted that oral appliances may form part of the management approach for appropriately selected patients, with treatment decisions based on professional assessment and individual clinical circumstances.

Smartee Launches SA/SA Plus and AG KIDS for International Markets

The Summit also served as the international launch platform for two Smartee product systems: Smartee SA/SA Plus and Smartee AG KIDS.

Smartee SA/SA Plus is designed to address clinical needs associated with primary snoring and mild-to-moderate obstructive sleep apnea (OSA). The system incorporates a locking mechanism into clear aligner technology, providing an option for patients who may require both snoring-related management and orthodontic treatment.

Smartee AG KIDS is a craniofacial growth guidance system developed for patients aged 3 to 16. The system is designed to support growth management across the sagittal, vertical and transverse dimensions, together with orofacial myofunctional training appliances, providing clinicians with an integrated approach to managing dentofacial growth and development.

Building a Broader Platform for Global Academic Exchange

Following the scientific sessions, participating clinicians and partners highlighted the clinical relevance of the program, particularly its combination of case-based learning and cross-disciplinary discussion.

One attendee from the United Kingdom commented:

"We got to meet many interesting orthodontists and clinicians who approach treatment differently in different parts of the world. I found that really inspiring."

As Smartee's first large-scale academic summit held overseas, the Mallorca event marked a further step in the company's international academic development, moving beyond product and technology introduction toward broader clinical discussion across multiple disciplines.

Mr. Garie Zhou, Director of International Business at Smartee, said the company plans to continue developing international academic exchange, professional education and clinical research across areas including GS technology, early orthodontics and dental sleep medicine.

Through continued collaboration with doctors and partners across different markets, Smartee aims to support the exchange of clinical experience and the development and application of clear aligner technologies in international practice.

Following the Mallorca Summit, Smartee plans to continue expanding its international academic platform, with Rome planned as the next European Summit destination in 2027.

Share this article

STUART, Fla., Oct. 2, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company ("Health In Tech" or the "Company"), today announced that representatives from the Company's management and investor relations teams will participate in the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026, at the Sheraton New York Times Square Hotel in New York City.

Company representatives will host one-on-one meetings with institutional investors throughout the day.

Institutional investors interested in meeting with Health In Tech at the conference are encouraged to contact their Craig-Hallum representative or the Company's Investor Relations team at [email protected] to arrange a meeting.

About Health In Tech

Health In Tech, Inc. (Nasdaq: HIT) is an AI-enabled InsurTech platform company, which offers a marketplace that aims to improve processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, managing general underwriters ("MGUs") and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements relating to Health In Tech, Inc.'s ("Health In Tech," "we," "us" or "our") business strategy, product development and innovation, growth prospects, and future operating and financial performance. In some cases, forward-looking statements can be identified by terminology such as "believe," "may," "will," "potentially," "estimate," "continue," "anticipate," "intend," "expect," "could," "would," "project," "plan," "target" or similar expressions that are predictions of or indicate future events or trends and that do not relate solely to historical matters. Forward-looking statements in this press release include, but are not limited to, statements regarding our planned participation in the 17th Annual Craig-Hallum Alpha Select Conference.

These forward-looking statements are based on current expectations and beliefs concerning future events and developments and their potential effects on Health In Tech and are subject to numerous known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of Health In Tech's control, that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These factors include, but are not limited to: our ability to obtain funding for our operations and to enhance our current systems and expand our service offerings; the success, cost and timing of our product development activities; our ability to attract and retain key personnel and qualified employees; our ability to attract new customers and to develop new, and enhance existing, products and services; the impact of competition in our industry and innovation by our competitors; risks related to cybersecurity incidents or other network disruptions; risks related to the use of third-party artificial intelligence; our ability to comply with new or modified laws and regulations applicable to our business, including with respect to the insurance services industry and data privacy requirements; our ability to protect our intellectual property rights and maintain and build our brand; the future trading price of our common stock; and other risks and uncertainties described in the "Risk Factors" section of our most recent Annual Report on Form 10-K and our subsequent Quarterly Reports on Form 10-Q and other filings with the U.S. Securities and Exchange Commission.

Any forward-looking statement made in this press release speaks only as of the date of this press release. New risks and uncertainties may emerge from time to time, and it is not possible for Health In Tech to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this press release. Except as required by applicable law, Health In Tech does not undertake, and expressly disclaims, any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.

Investor Contact:

Health In Tech Investor Relations

[email protected]

SOURCE Health In Tech Inc.

Share this article

- STARt-002 is the first clinical study to combine a Vβ6-selective T-cell agonist with an ADC, pairing invikafusp alfa's selective T-cell activation with TRODELVY's TROP2-directed delivery of a cytotoxic payload

- Oral presentation will feature interim clinical results from two distinct metastatic breast cancer populations, triple-negative and HR-positive/HER2-negative, building on initial results presented at AACR 2026

CAMBRIDGE, Mass., Oct. 2, 2026 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapies for oncology and inflammation and immunology (I&I), today announced that interim results from the STARt-002 clinical study have been selected for an oral presentation at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting, taking place November 4–8, 2026, in Phoenix, Arizona.

"Invikafusp alfa is designed for antigen-rich tumors. ADCs like TRODELVY help create that state by releasing tumor antigens and inflaming the tumor microenvironment, priming less immunogenic tumors for T-cell-mediated responses," said Kevin Chin, M.D., Chief Medical Officer of Marengo Therapeutics. "STARt-002 is the first clinical study to test this hypothesis by pairing a selective T-cell agonist with an ADC, and this combination could extend invikafusp alfa's reach beyond tumors that are antigen-rich on their own. Triple-negative and HR-positive/HER2-negative metastatic breast cancer are two settings where patients still have limited options after standard therapies. We look forward to presenting interim results from both cohorts at SITC."

STARt-002 is the company's Phase 1b/2 trial evaluating invikafusp alfa in combination with TRODELVY® (sacituzumab govitecan-hziy) in patients with metastatic breast cancer. The Phase 2 portion is evaluating two distinct patient populations: metastatic triple-negative breast cancer (TNBC) and HR-positive/HER2-negative metastatic breast cancer. Following completion of the safety lead-in, both expansion cohorts are enrolling at the recommended Phase 2 dose at select cancer centers across North America. The SITC presentation will feature interim results from both expansion cohorts, and Marengo expects to report additional data in 2027.

The STARt-002 combination strategy reflects invikafusp alfa's long-term potential as an immuno-oncology backbone and builds on STARt-001, a Phase 1/2 trial evaluating invikafusp alfa monotherapy in patients with PD-1-resistant, biomarker-enriched solid tumors, including TNBC. Updated STARt-001 results will be presented during an oral presentation at the European Society for Medical Oncology (ESMO) 2026 Congress, taking place October 23–27 in Madrid, Spain.

Presentation Details

- Title: Initial clinical results from START-002: A Phase 1b/2 study of invikafusp alfa, a first-in-class dual T-cell agonist, in combination with sacituzumab govitecan in triple-negative or HR+/HER2- mBC

- Abstract Number: 514

- Session: Oral Abstract Session 3

- Date/Time: Saturday, November 7, 2026 3:30PM MT

- Presenter: Steven Isakoff, MD, PhD, MMSc; Mass General Brigham

About Marengo Therapeutics

Marengo Therapeutics, Inc., a clinical-stage biotech company, develops novel TCR-targeting antibodies that selectively modulate common and disease-specific T-cell subsets of the germline TCR repertoire to provide durable protection against cancer and autoimmune diseases. With a passionate team of dedicated scientists experienced in immunology and oncology, and three proprietary platforms, Selective T Cell Activation Repertoire (STAR), Trispecific T Cell Engager (TriSTAR) and T Cell Depletor (MSTAR), Marengo is working to selectively target the right T cells in the right patients to create a world in which everyone's immune system can defeat cancer and autoimmune diseases. To learn more, visit marengotx.com.

About Invikafusp Alfa (STAR0602)

Invikafusp alfa (STAR0602) is the lead candidate from Marengo's STAR™ platform and a first-in-class, bispecific dual T-cell agonist. It is designed to selectively activate Vβ6 T cells, a common T-cell subset present across many tumor types, by combining a non-clonal mode of TCR activation with a T-cell co-stimulatory signal in a single molecule. This approach promotes the expansion of clonally diverse, effector memory Vβ6 T cells, with the goal of enhancing and sustaining antitumor immunity. Invikafusp alfa was designed to restore and amplify antitumor immunity in patients who have progressed on, or are insensitive to, prior immune checkpoint blockade.

About the STARt-002 Clinical Study

STARt-002 (NCT06827613) is a Phase 1b/2, open-label, multicenter study investigating the combination of invikafusp alfa and TRODELVY® in patients with unresectable, locally advanced or metastatic breast cancer. The trial consists of a safety lead-in phase followed by two dose-expansion cohorts: one in metastatic TNBC and one in HR-positive/HER2-negative metastatic breast cancer. More information is available at clinicaltrials.gov.

TRODELVY® is a registered trademark of Gilead Sciences, Inc.

Marengo Contacts:

Media | Peg Rusconi | [email protected]

Investors | [email protected]

SOURCE Marengo Therapeutics

Share this article

DELRAY BEACH, Fla., Oct. 2, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Emulsifiers Market is projected to reach USD 18.15 billion by 2031, up from USD 12.15 billion in 2026, at a CAGR of 8.4% over the forecast period.

Browse 243 market data tables and 52 figures spread through 225 pages and an in-depth TOC on the "Emulsifiers Market - Global Forecast to 2031"

Emulsifiers Market Size & Forecast:

- Market Size Available for Years: 2023-2031

- 2026 Market Size: USD 12.15 billion

- 2031 Projected Market Size: USD 18.15 billion

- CAGR (2026-2031): 8.4%

Emulsifiers Market Trends & Insights:

- The emulsifiers market is growing at a high rate due to the increased demand in food & beverage, cosmetics, pharmaceuticals, and industrial applications. The drivers are the increased demand for processed and convenience foods, as emulsifiers are required to maintain texture, stability, and shelf life in packaged products. The growing trend toward healthier food options, low-fat, low-calorie, and clean-label products is also a major driver, as emulsifiers help meet these consumer demands without compromising on product quality. The expansion of the cosmetics and personal care industry, along with increasing consumer preference for natural and bio-based ingredients, is driving the demand for emulsifiers in skincare, haircare, and beauty formulations. The pharmaceutical sector's growth, particularly in drug delivery systems, is another key factor, with emulsifiers enhancing bioavailability and stability in medicinal products. Advancements in emulsifier technology may lead to multifunctional emulsifiers produced through greener processes, creating market opportunities and improving competition. Also, in the emerging markets of Asia Pacific and South America, the demand for emulsifier-based products is expected to increase due to urbanization and changes in consumer behavior. The emulsifiers market is expected to continue its long-term growth path, influenced by continuous innovation, increasing application areas, and changing consumer requirements.

- By region, Asia Pacific accounted for a 19.9% share of the emulsifiers market in 2025, supported by the expansion of the food and beverage processing industry, rising consumption of processed and convenience foods, and increasing demand for bakery, confectionery, dairy, plant-based, and functional food products across China, India, Japan, and South Korea.

- By source, the bio-based emulsifier is estimated to grow at an 8.8% CAGR between 2026 and 2031, supported by increasing demand for natural, plant-derived, renewable, and clean-label ingredients across food, personal care, and other formulation applications.

- By product type, Lecithin holds a 55.5% share of the emulsifiers market in 2025, supported by its broad use as a natural emulsifying and dispersing ingredient in food and beverage applications. Increasing use of lecithin in bakery products, confectionery, dairy products, infant nutrition, processed foods, and plant-based formulations is supporting demand due to its ability to improve ingredient dispersion, texture, mixing, and product stability.

- By application, food emulsifiers are anticipated to record a CAGR of 8.9% during the forecast period, driven by increasing demand for processed and convenience foods, bakery and confectionery products, dairy and dairy alternatives, sauces, dressings, beverages, and plant-based foods.

- BASF SE (Germany), Archer Daniels Midland (ADM) (US), Cargill, Incorporated (US), Evonik Industries AG (Germany), Kerry Group plc (Republic of Ireland) was identified as some of the star players in the emulsifiers market, given their strong market share and product footprint.

- Kraton Corporation, Palsgaard, Stepan Company, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240653061

The market has been witnessing strong growth because of its widespread use across industries such as food and beverages, cosmetics, pharmaceuticals, and industrial products. The demand for processed and ready-to-eat foods, especially low-fat and low-calorie products, is driving rapid growth in the emulsifiers market. Emulsifiers are incorporated because they improve texture, stability, and shelf life in most modern food processing. The cosmetics and personal care industry, where emulsifiers play an important role in stabilizing creams, lotions, and other skincare and haircare product formulations, is the biggest driver of growth. Other pharmaceutical applications, such as new drug delivery systems, are also broadening the scope of the market. Significant industrial uses include paints, coatings, and detergents, which also contribute greatly to the expansion of this market. Growth in developing economies, mainly Asia Pacific and South America, is increasingly stimulated by urbanization, rising disposable incomes, and shifting consumer preferences.

Synthetic emulsifier is projected to have the largest market share in 2025.

Synthetic emulsifiers are expected to maintain the largest market share in the emulsifiers market because of their cost-effectiveness, versatility, and widespread applicability across industries. They offer excellent functional properties, including high emulsifying efficiency, stability under extreme conditions such as varying temperatures and pH levels, and extended shelf life, making them highly suitable for large-scale industrial applications. Synthetic emulsifiers such as mono- and diglycerides, polysorbates, and lecithin derivatives have become a staple in the food industry to improve texture, stabilize emulsions, and extend shelf life due to the growing demand for processed and convenience foods. This is further expanded into industrial use, including paints, coatings, lubricants, and detergents, where superior stability and performance under extreme conditions are important. Synthetic emulsifiers also have well-established supply chains and manufacturing infrastructure, ensuring consistent quality and accessibility at competitive prices across the globe. However, synthetic emulsifiers are under challenge from the increasing preference of consumers for natural, bio-based ingredients and regulatory pressure related to health and environmental issues. Addressing these issues, producers are innovating in the synthetic segment toward creating products more environmentally friendly and have lower toxicity, thereby retaining relevance in a constantly shifting market environment.

Food segment to have the highest market share in the emulsifiers market.

Food would account for the biggest share of the market for emulsifiers due to the key role these play in the enhancement of quality, texture, and shelf life in the majority of food products. In the formulation of baked goods, confectionery, dairy products, margarine, dressings, and processed foods, emulsifiers play a huge role, providing uniformity and stability in their formulations. Growing global demand for convenience and processed foods, which arises due to urbanization, lifestyle changes, and rising incomes, has increased the requirements for emulsifiers considerably. Further, the health-conscious attitude among consumers has increased demand for low-fat, low-calorie, and clean-label products. Emulsifiers can help manufacturers meet this need because they enhance product functionality and sensory appeal even when fats or calories are reduced. New developments in food emulsifiers, such as bio-based and allergen-free varieties, are increasingly finding application in health-oriented and organic food categories. In addition, the Asia Pacific region is expected to show an increase in the consumption of emulsifier-based food products mainly due to rapid urbanization, an increase in middle-class populations, and changing dietary patterns. Another factor that sustains the dominance of the food segment is the research and development investment by the manufacturers for developing multifunctional emulsifiers tailored specifically for different food applications. As consumer preferences and food trends change, the food segment is likely to continue to be the largest and most dynamic contributor to the emulsifiers market.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=240653061

Europe to be the third-largest market during the forecast period

Europe is the third-largest market for emulsifiers industry driven by its mature food and beverage, cosmetics, and pharmaceutical industries. The region's well-established food processing sector has a consistent demand for emulsifiers, especially in bakery, confectionery, dairy, and convenience food products. Health-conscious consumers in Europe are also driving the market for clean-label and low-fat food products, where emulsifiers play a crucial role in maintaining texture and stability without compromising quality. Another major contributor is the cosmetics and personal care industry in Europe, driven by the high requirement of quality and sustainability for beauty products from this region. Emulsifiers are used extensively across various skincare, haircare, and makeup formulations to improve product texture and stability. The pharmaceutical industry remains expanding in Europe, leveraging emulsifiers for a variety of drug delivery systems. While Europe is a mature market compared to the rapidly growing regions of Asia-Pacific and North America, innovation in bio-based and sustainable emulsifiers is driving growth. The region's stringent regulations on food and cosmetic ingredients have encouraged the development of natural and environmentally friendly emulsifier solutions, aligning with consumer and regulatory demands. Europe is focusing on sustainability, quality, and advanced formulations.

LYSAKER, Norway, Oct. 2, 2026 /PRNewswire/ -- Aker BP has appointed a new executive management team, effective 1 January 2027. The new team will be organised around the company's value chain, from exploration to production, to strengthen collaboration, reduce complexity and improve execution.

Until year-end, the new executive management team will design a new operating model for the company. The aim is to mature projects faster and more cost-effectively through the value chain, with fewer organisational interfaces and less complexity. The current executive management team will remain in place until 1 January 2027.

The operating model will build on the company's work with industrial data and artificial intelligence over the past decade, as well as its close collaboration with alliance partners.

"Aker BP is uniquely positioned for long-term value creation on the Norwegian continental shelf. The changes we are making will strengthen that position. The shelf is changing, and tomorrow's shelf requires something different from us than yesterday's did. We are now positioning the company for that future. I would also like to thank the current executive management team. It is under their leadership that we have laid the foundation for the steps we are taking now," says Karl Johnny Hersvik, CEO of Aker BP.

The executive management team is led by CEO Karl Johnny Hersvik and consists of:

Value chain

- Petter Sørhaug – Find & Develop

- Tommy Sigmundstad – Build

- Lars Høier – Produce

- Øystein Arvesen – Optimise

- Knut Sandvik – PDO Projects

Strategic and support functions

- David Tønne – CFO

- Marit Blaasmo – Services

- Thomas Hoff-Hansen – Digital

- Paula Doyle – Strategic Innovation

- Rolf Nystein –Transformation

The work on the new organisation is being carried out in close cooperation with employee representatives and the company's safety delegate service.

Contacts

Tore Dammann Langballe, VP Communications, tel.: +47 907 77 841

Kjetil Bakken, Head of Investor Relations, tel.: +47 918 89 889

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/aker-bp-asa/r/aker-bp-appoints-new-executive-management-team,c4403917

SOURCE Aker BP ASA

Share this article

NYSE American / TSX

Symbol: TMQ

VANCOUVER, BC, Oct. 2, 2026 /PRNewswire/ -- Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) ("Trilogy Metals", "Trilogy" or the "Company") announces its financial results for the third quarter ended August 31, 2026. Details of the Company's financial results are contained in the interim unaudited consolidated financial statements and Management's Discussion and Analysis which will be available on the Company's website at www.trilogymetals.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. All amounts are in United States dollars unless otherwise stated.

Financial and Operational Highlights

- Cash balance of $31.2 million as at August 31, 2026, with adjusted working capital of $30.3 million, providing financial flexibility to fund the Company's share of Upper Kobuk Mineral Projects ("UKMP") initiatives, with the Company's share of Ambler Metals LLC's ("Ambler Metals") fiscal 2026 budget substantially funded.

- Publication of a coordinated federal and state permitting schedule for the Arctic Project on the Federal Permitting Dashboard on July 13, 2026. The schedule sets an estimated 29-month integrated review timetable targeting a Record of Decision in September 2028, confirms the U.S. Army Corps of Engineers ("USACE") as lead federal agency, and integrates State of Alaska permitting under the first statewide FAST-41 Memorandum of Understanding in the nation.

- Closing of the DOW $35.6 million strategic equity investment subsequent to quarter end on September 11, 2026. The full proceeds received by Trilogy Metals and South32 Limited ("South32") are committed to Ambler Metals to advance exploration and development of the UKMP in northwestern Alaska, and the DOW has committed to work in good faith to help facilitate financing required for construction of the proposed 211-mile, industrial-use-only Ambler Road (or "Ambler Access Project") in coordination with the State of Alaska and the Alaska Industrial Development and Export Authority.

- Publication of the Notice of Intent to prepare an Environmental Impact Statement by the USACE subsequent to quarter end in September 2026, formally commencing the National Environmental Policy Act ("NEPA") review and public scoping phase for the Arctic Project on schedule.

Tony Giardini, President and CEO of Trilogy Metals, commented: "The third quarter and the weeks that followed have been transformational for Trilogy Metals. The Department of War's investment in Trilogy was successfully closed. On the permitting front, the Arctic Project now has a transparent, coordinated federal and state schedule, and the Notice of Intent, published on schedule, has formally launched the NEPA review on a path to a Record of Decision in September 2028. With a defined permitting timeline, the investment by the U.S. Government, and a clear line of sight to a Record of Decision, Arctic is well positioned to become a cornerstone of a secure, domestic copper supply chain."

Selected Results

The following selected financial information is prepared in accordance with U.S. GAAP.

For the three-month period ended August 31, 2026, the Company reported a net income of $0.2 million compared to a net loss of $1.7 million for the three-month period ended August 31, 2025. The net income was primarily driven by a mark-to-market gain arising from the change in fair value of the derivative liability related to the Company's obligation to issue common shares (the "Common Shares") and warrants to purchase Common Shares (the "Warrants") to the DOW, and was offset by an increase in the Company's 50% share of loss from its investment in Ambler Metals. The increase in the Company's share of loss from Ambler Metals was primarily driven by budgeted exploration activities undertaken during the period.

For the nine-month period ended August 31, 2026, the Company reported a net loss of $13.2 million, compared to a net loss of $7.5 million for the same period in 2025. The increase in net loss was primarily driven by two non-cash items: (i) stock-based compensation expense related to the Company's annual grant with higher Black-Scholes values in the current year compared to the prior year; and (ii) increased activity related to budgeted exploration activities at Ambler Metals which resulted in a larger amount for the Company's share of loss on equity investment and an increase in personnel costs due to the addition of senior staff. This was offset by a mark-to-market gain arising from the change in fair value of the derivative liability related to the Company's obligation to issue the Common Shares and Warrants to the DOW.

Closing of Strategic Equity Investment from the United States Department of War

On August 28, 2026, the Company entered into an Investment Agreement (the "Investment Agreement") with the DOW, relating to the DOW's strategic investment in the Company (the "Strategic Investment"). On September 11, 2026, the Company completed the Strategic Investment by the DOW. At closing, the Company issued 8,215,570 units to the DOW at a price of $2.17 per unit for gross proceeds of approximately $17.8 million. Each unit consisted of one Common Share and three-quarters of one Warrant, resulting in the issuance of Warrants to acquire up to 6,161,678 additional Common Shares at an exercise price of $0.01 per Common Share. The Warrants have a ten-year term and become exercisable upon the earlier of the completion of Phase 1 of the Ambler Access Project and the achievement of certain specified usage milestones for the Ambler Access Project, or a change of control of the Company.

The Company received gross proceeds of approximately $17.8 million upon closing of the Strategic Investment. The proceeds are specifically designated to fund an additional cash capital contribution to Ambler Metals and, therefore, do not represent additional liquidity available to fund the Company's general corporate activities. South32 will make a corresponding contribution on a pro-rata basis, such that the Company's 50% ownership interest in Ambler Metals will remain unchanged.

Following the issuance of the Common Shares to the DOW, and the DOW's separate acquisition of Common Shares from South32, the DOW holds approximately 9.1% of the Company's outstanding Common Shares. In connection with closing, the Company, through its wholly-owned subsidiary Trilogy Metals US, and the DOW, among other parties, also entered into a Cooperation Agreement (the "Cooperation Agreement", and together with the Investment Agreement and other ancillary agreements, the "DOW Transaction Documents"). Pursuant to the DOW Transaction Documents, the DOW is entitled to (i) designate one independent third-party nominee for appointment to the Company's Board of Directors, and (ii) appoint a representative to attend meetings of the Company's Board of Directors in an observer capacity.

The closing also resulted in the settlement of the derivative liability previously recognized in connection with the Company's obligation to issue Common Shares and Warrants to the DOW. Upon settlement, the Company recognized a gain of approximately $3.9 million, representing the change in the derivative liability through the closing date. The derivative liability was extinguished upon issuance of the underlying securities, and the applicable amounts were reclassified to share capital and contributed surplus. As a result, subsequent changes in the value of the Common Shares will no longer result in fair value adjustments associated with this derivative liability. The gain recognized on settlement is non-cash in nature and therefore does not affect the Company's cash flows.

The Strategic Investment represents a source of funding for the Company's investment in Ambler Metals while maintaining the Company's 50% ownership interest in the joint venture. Future exercise of the Warrants could result in future dilution of share capital, although such exercise is subject to the specified conditions described above.

Liquidity and Capital Resources

During the nine-month period ended August 31, 2026, the Company used $4.9 million in operating activities and $17.0 million in investing activities, and raised $1.4 million in financing activities. Operating expenditures were driven primarily by corporate salaries, professional fees and annual regulatory filing fees with the U.S. and Canadian securities commissions. In addition, the Company contributed $17.0 million for its share of funding to Ambler Metals. These cash outflows were offset by $1.4 million in proceeds from financing activities, primarily from the Company's at-the-market equity program through which the Company may offer and issue up to $200 million of Common Shares from time to time pursuant to an equity distribution agreement dated November 7, 2025, and from the exercise of stock options.

As at August 31, 2026, the Company had cash and cash equivalents of $31.2 million and adjusted working capital of $30.3 million, which are current assets less current liabilities excluding the derivative liability which will be settled by way of the issuance of the Common Shares and Warrants. There is sufficient cash on hand for the next twelve months from the end of the Company's most recent fiscal quarter, including funding its remaining fiscal 2026 corporate budget of $1.1 million. The Company's share of Ambler Metals' fiscal 2026 budget is $17.5 million, of which $17.0 million had been funded as at August 31, 2026.

Future cash requirements may vary materially from current expectations. Beyond the next twelve months, the Company may need to raise additional funds in the future to support its operations and administration expenses. Future sources of liquidity are likely in the form of an equity financing but may include debt financing, convertible debt, exercise of options, or other means, including, but not limited to, utilizing the Company's ATM program.

Qualified Persons

Richard Gosse, P.Geo.

DELRAY BEACH, Fla., Oct. 2, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the global Smart Gas Meter Market size is projected to grow from USD 2.55 billion in 2026 to USD 3.74 billion by 2031 at a compound annual growth rate (CAGR) of 8.0% during the forecast period.

Browse over 150 market data tables and 44 figures spread across 220 pages, and an in-depth TOC of the "Smart Gas Meter Market —Global Forecast to 2031."

The global Smart Gas Meter Market is continuing to grow as gas utilities modernize distribution networks, expand automated meter reading (AMR) and advanced metering infrastructure (AMI), and move from conventional mechanical meters toward connected and digitally managed systems. Smart gas meters are increasingly adopted to improve billing accuracy, reduce the need for manual meter reading, enhance network safety, and give utilities better visibility into consumption and network conditions. Market development is also supported by advances in ultrasonic and solid-state metering, two-way communication, remote shutoff, leak detection, and IoT-enabled monitoring. Itron and Landis+Gyr are expanding ultrasonic smart gas meter platforms that combine advanced measurement with AMI connectivity and safety features, while Apator offers smart gas meters supporting NB-IoT and Wireless M-Bus communication.

The Smart Gas Meter Market is moving beyond basic remote meter reading toward integrated digital gas-network management, creating opportunities across communication modules, meter-data platforms, remote monitoring, and analytics. Retrofit solutions allow utilities to add two-way AMI capabilities to existing diaphragm meters without replacing the entire metering infrastructure, while multi-utility platforms enable gas, electricity, water, and thermal meters to operate through shared communication networks. Diehl Metering, for example, provides AMR/AMI solutions that connect meters with communication networks and software for data management and analysis, while Landis+Gyr combines smart gas meters, retrofit modules, IoT connectivity, and remote operational capabilities. As utilities continue to invest in network modernization, the market is increasingly moving toward connected gas-metering ecosystems in which metering hardware, communications, safety functions, and software work together to improve the efficiency, visibility, and responsiveness of gas distribution networks.

Smart Gas Meter Market Size & Forecast:

- Market Size Available for Years: 2022–2031

- 2025 Market Size: USD 2.36 billion

- 2031 Projected Market Size: USD 3.74 billion

- CAGR (2026–2031): 8.0%

Smart Gas Meter Market Trends & Insights:

- By region, North America is expected to register a CAGR of 5.2% in the Smart Gas Meter Market during the forecast period.

- By type, the smart diaphragm gas meters segment accounted for a 79.7% market share in 2025.

- By technology, the advanced metering infrastructure (AMI) segment held a 71.7% share of the Smart Gas Meter Market in 2025.

- By application, the hardware segment is expected to register the highest growth rate from 2026 to 2031.

- By end user, the residential segment is projected to be the fastest-growing during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256341634

Residential segment to be the largest contributor to market growth from 2026 to 2031

By end user, the residential segment is anticipated to dominate the Smart Gas Meter Market during the forecasted period due to the increasing focus on energy efficiency. Asia Pacific held the largest share of the market for the residential segment in 2025. Furthermore, specific government mandates are accelerating adoption — for example, China's nationwide AMI rollout targets, Japan's smart meter deployment programs, and regulations in the UK, France, and Italy requiring the installation of smart gas meters in residential buildings. These country-level initiatives, along with similar programs in Australia, continue to drive strong demand in the residential segment.

Ultrasonic gas meters segment is expected to witness strong growth between 2026 and 2031

By type, the ultrasonic gas meters segment is likely to record a high CAGR in the Smart Gas Meter Market during the forecast period, as utilities are looking for advanced measurement technologies that combine accurate gas measurement with digital communication and safety features. Ultrasonic gas meters are highly advantageous as they do not rely on traditional moving parts. This design allows manufacturers to incorporate electronic sensing, communication, and monitoring functions into compact platforms. For instance, Itron's Intelis platform combines ultrasonic metrology with built-in safety features. Similarly, Landis+Gyr's Surent G480 integrates solid-state ultrasonic measurement with two-way cellular communication and automatic safety shutoff capabilities. These advanced features make ultrasonic meters ideal for AMI-enabled gas networks, where meters can function as connected endpoints, transmitting consumption and operational data. This development presents opportunities for manufacturers to create ultrasonic platforms that include integrated communication, remote diagnostics, safety monitoring, and data management capabilities. As utilities increasingly adopt advanced metering technologies and modernize their gas infrastructure, the demand for ultrasonic smart gas meters is expected to rise.

Asia Pacific dominated the Smart Gas Meter Market in 2025

By region, Asia Pacific accounted for the largest share of the Smart Gas Meter Market in 2025. driven by utility digitalization, rapid urbanization, expanding city-gas distribution, and government-backed smart-city initiatives. China remained the largest market, supported by extensive gas-network expansion and smart-utility investments, while India's accelerating piped-gas connections created significant deployment potential. Utilities increasingly prioritized remote meter reading, accurate billing, leakage detection, operational efficiency, and real-time consumption visibility. Replacement cycles in mature markets such as China and Japan further supported demand, while emerging Southeast Asian markets opened incremental opportunities. Collectively, these factors strengthened the business case for connected AMI/IoT-enabled gas metering solutions across the region.

Top Companies in Smart Gas Meter Industry:

The Smart Gas Meter Industry include Badger Meter, Inc. (US), Kamstrup (Denmark), Diehl Stiftung & Co. KG (Germany), Landis+Gyr (Switzerland), Aclara Technologies (US), Xylem (US), Itron, Inc. (US), Bmeters Srl (Italy), Honeywell International Inc. (US), MOM Co. Ltd. (South Korea), WaterTech (Arad Group) (Israel), Zenner International GmbH & Co. KG (Germany), Neptune Technology Group Inc. (US), Iskraemeco Group (Slovenia), and Sagemcom (France). These companies are strengthening their market positions through smart water meter portfolio expansion, energy-efficiency improvements, product innovation, geographic expansion, strategic acquisitions, and investments in water utilities and industrial applications.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=256341634

Smart Gas Meter Market - Investment & funding + Merger & Acquisition

Investment Funding Context

The Smart Gas Meter Market is witnessing increased investment from metering manufacturers, utility technology providers, and gas distribution companies as utilities accelerate network digitalization, remote meter reading, and AMI deployment. Investment is increasingly focused on ultrasonic and solid-state metering, communication modules, AMI platforms, meter-data management, remote safety functions, and software-enabled utility services. Itron has expanded beyond traditional metering hardware through investments in software and utility infrastructure capabilities, including its acquisition of Urbint for USD 325 million in 2025 and Locusview for approximately USD 525 million, completed in January 2026. These acquisitions strengthen Itron's capabilities in AI-powered operational resilience and digital infrastructure management. Apator is also expanding its smart metering portfolio, with its gas business benefiting from the growing adoption of remotely readable gas meters and increasing customer interest in ultrasonic metering technologies.

Revenue Shift Context

The Smart Gas Meter Market is gradually moving beyond conventional meter sales toward connected metering, communication infrastructure, data-management platforms, remote monitoring, and utility software. Revenue opportunities are increasingly emerging from the digitalization of existing gas-metering infrastructure, including retrofit communication modules that enable remote meter reading without requiring a complete meter replacement. Landis+Gyr's 2026 agreement with Origin Energy highlights this shift, with intelligent IoT modules, communication technology, and a data-management platform being deployed across existing gas-metering assets in Australia. Apator is also involved in large-scale meter replacement programs, including a project with Polska Spółka Gazownictwa to replace traditional diaphragm meters with remotely readable smart meters. This reflects the market's broader shift toward integrated solutions that combine metering hardware, connectivity, software, analytics, and long-term utility services.

Mergers and Acquisitions

M&A activity in the Smart Gas Meter Market and the broader utility-technology ecosystem is increasingly focused on strengthening software, analytics, connectivity, predictive maintenance, and digital utility infrastructure rather than simply expanding physical meter portfolios. Itron's acquisitions of Urbint and Locusview reflect this shift toward AI-enabled operational resilience and digital infrastructure management.